Fig. 1
From: SGLT2 inhibitors and lower limb complications: an updated meta‐analysis
The risk of amputation and PAD in patients with SGLT2i treatment. a The risk of amputation in patients with SGLT2i treatment. b The risk of PAD in patients with SGLT2i treatment. PAD, peripheral arterial disease; SGLT2i, sodium glucose co-transporter 2 inhibitor